Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain
Examining the Feasibility and Acceptability of a Journaling Intervention in Alleviating Temporomandibular Pain
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether a 2-week gratitude journaling activity is feasible and acceptable for individuals with Temporomandibular Disorder (TMD) and chronic overlapping pain. The study will also look at whether this activity is helpful in reducing pain and how much it interferes with daily life. The primary aims of this study are to:
- Assess whether individuals with TMD and chronic overlapping pain are able to complete the 2-week gratitude journaling activity as planned (feasibility).
- Evaluate how acceptable participants find the gratitude journaling activity (acceptability). The secondary aim of this study is to:
- Explore whether the gratitude journaling activity reduces pain and its impact on daily life, compared to a general wellness journaling activity. Participants will:
- Attend two in-person visits to complete questionnaires and take part in tests that measure how sensitive they are to pressure and heat.
- Complete a 2-week journaling activity at home, writing in their journal on three days of their choice per week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2025
CompletedFirst Posted
Study publicly available on registry
May 18, 2025
CompletedStudy Start
First participant enrolled
August 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 6, 2026
May 1, 2025
1.2 years
May 8, 2025
January 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Participant Retention
Percentage of participants who initiate treatment/intervention and complete the post-intervention assessment at the 4-week time-point.
Baseline to Week 4
Treatment Satisfaction
Single-item Treatment Satisfaction Questionnaire: Response to self-reported item assessing overall satisfaction with the treatment. The item is rated on a 1 to 4 scale (1 = Quite Dissatisfied to 4 = Very Satisfied) with the mean value calculated. A higher score indicates greater satisfaction with the treatment.
Week 4
Secondary Outcomes (2)
Pain Intensity
Baseline, Week 4
Pain Interference
Baseline, Week 4
Study Arms (2)
Gratitude Intervention
EXPERIMENTALGeneral Wellness
ACTIVE COMPARATORInterventions
Participants in this group will receive a general wellness journal where they will be asked to reflect on three things that happened, or they did during the day (daily activities). Journaling will take place from the comfort of their home on three days of their choice per week, for a total duration of two weeks.
Participants in this group will receive a gratitude journal where they will be asked to write down three things they are grateful for each day and reflect why they are grateful for these things. Journaling will take place from the comfort of their home on three days of their choice per week, for a total duration of two weeks.
Eligibility Criteria
You may qualify if:
- participants between the ages of 18 and 80
- pain in the temporomandibular (TMD) region (jaw and/or temple area)
- duration of pain is at least 3 months
- average pain score ≥4 on a 0-10 numerical rating scale over the past week
- have at least one additional chronic overlapping pain condition (COPC) including fibromyalgia, irritable bowel syndrome, migraine-type headache, tension-type headache, low back pain, interstitial cystitis/painful bladder syndrome or chronic prostatitis, myalgic encephalomyelitis/chronic fatigue syndrome, vulvodynia, and painful endometriosis.
- able to read, understand, and write in English.
You may not qualify if:
- history of TMD surgery
- neoplasm or injury/trauma to the TMD area
- cancer-related pain
- scheduled for any surgeries during the study time-frame
- current participation in another clinical trial or psychological treatment for any pain-related condition that would interfere with study outcomes
- pregnant or lactating
- severe motor impairments (e.g., muscular dystrophy)
- severe psychiatric conditions (e.g., uncontrolled mood disorders)
- severe neurological or cognitive impairments (e.g., uncontrolled Parkinson's disease)
- any other conditions that in the opinion of study investigators could make participation in the study unsafe
- use of opioids within 48 hours prior to laboratory visit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32610, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2025
First Posted
May 18, 2025
Study Start
August 11, 2025
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 6, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share